| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premature Birth | 12 | 2025 | 95 | 6.510 |
Why?
|
| Patient Readmission | 20 | 2025 | 122 | 6.440 |
Why?
|
| Pregnancy | 75 | 2025 | 1772 | 5.820 |
Why?
|
| Postpartum Period | 18 | 2025 | 92 | 4.720 |
Why?
|
| Hypertension, Pregnancy-Induced | 9 | 2025 | 27 | 4.480 |
Why?
|
| Puerperal Disorders | 10 | 2025 | 16 | 4.330 |
Why?
|
| Pre-Eclampsia | 8 | 2023 | 67 | 4.070 |
Why?
|
| Decision Making | 7 | 2025 | 249 | 3.930 |
Why?
|
| Venous Thromboembolism | 8 | 2021 | 22 | 3.610 |
Why?
|
| Hospitalization | 21 | 2025 | 485 | 3.060 |
Why?
|
| Delivery, Obstetric | 7 | 2025 | 48 | 2.910 |
Why?
|
| Postpartum Hemorrhage | 8 | 2023 | 18 | 2.730 |
Why?
|
| Abruptio Placentae | 5 | 2025 | 7 | 2.400 |
Why?
|
| Pregnancy Complications | 6 | 2025 | 140 | 2.350 |
Why?
|
| Female | 87 | 2025 | 24698 | 2.350 |
Why?
|
| Pregnancy Complications, Cardiovascular | 7 | 2024 | 12 | 2.150 |
Why?
|
| Corpus Striatum | 3 | 2025 | 121 | 2.080 |
Why?
|
| Humans | 100 | 2025 | 43102 | 1.980 |
Why?
|
| United States | 41 | 2025 | 5205 | 1.950 |
Why?
|
| Retrospective Studies | 27 | 2025 | 2544 | 1.920 |
Why?
|
| Heart Failure | 6 | 2024 | 302 | 1.840 |
Why?
|
| Infant, Newborn | 17 | 2025 | 972 | 1.800 |
Why?
|
| Pulmonary Edema | 4 | 2023 | 12 | 1.740 |
Why?
|
| Pregnancy in Diabetics | 3 | 2025 | 8 | 1.720 |
Why?
|
| Risk Factors | 28 | 2025 | 3994 | 1.630 |
Why?
|
| Hospitals | 5 | 2021 | 117 | 1.510 |
Why?
|
| Cesarean Section | 8 | 2025 | 63 | 1.490 |
Why?
|
| Maternal Age | 5 | 2022 | 33 | 1.450 |
Why?
|
| Pregnancy Outcome | 7 | 2025 | 102 | 1.370 |
Why?
|
| Environmental Exposure | 4 | 2024 | 256 | 1.370 |
Why?
|
| Reward | 7 | 2025 | 112 | 1.350 |
Why?
|
| Models, Neurological | 4 | 2025 | 136 | 1.340 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 72 | 1.330 |
Why?
|
| Adult | 40 | 2025 | 13872 | 1.320 |
Why?
|
| Thromboembolism | 2 | 2020 | 20 | 1.290 |
Why?
|
| Young Adult | 26 | 2025 | 5080 | 1.290 |
Why?
|
| Maternal Mortality | 7 | 2021 | 26 | 1.260 |
Why?
|
| Cross-Sectional Studies | 18 | 2025 | 3156 | 1.260 |
Why?
|
| Opioid-Related Disorders | 3 | 2023 | 195 | 1.230 |
Why?
|
| Stroke | 3 | 2024 | 340 | 1.150 |
Why?
|
| Mental Disorders | 3 | 2025 | 392 | 1.140 |
Why?
|
| Phthalic Acids | 2 | 2025 | 18 | 1.110 |
Why?
|
| Adolescent | 23 | 2025 | 6081 | 1.100 |
Why?
|
| Cost-Benefit Analysis | 3 | 2025 | 179 | 1.090 |
Why?
|
| Databases, Factual | 10 | 2021 | 341 | 1.070 |
Why?
|
| Hysterectomy | 7 | 2025 | 38 | 1.050 |
Why?
|
| Ventral Tegmental Area | 5 | 2013 | 49 | 1.040 |
Why?
|
| Rats | 17 | 2025 | 3735 | 1.030 |
Why?
|
| Electrodes, Implanted | 2 | 2025 | 22 | 1.020 |
Why?
|
| Stillbirth | 3 | 2023 | 20 | 1.000 |
Why?
|
| Behavior, Animal | 5 | 2024 | 373 | 1.000 |
Why?
|
| Anticoagulants | 5 | 2021 | 122 | 0.990 |
Why?
|
| Pregnancy, High-Risk | 2 | 2018 | 8 | 0.980 |
Why?
|
| Critical Illness | 2 | 2016 | 47 | 0.980 |
Why?
|
| Electrophysiology | 2 | 2025 | 138 | 0.970 |
Why?
|
| Disseminated Intravascular Coagulation | 3 | 2021 | 3 | 0.970 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 65 | 0.970 |
Why?
|
| Shock | 3 | 2021 | 7 | 0.970 |
Why?
|
| Environmental Pollutants | 3 | 2025 | 201 | 0.960 |
Why?
|
| Perinatology | 3 | 2020 | 6 | 0.960 |
Why?
|
| Prenatal Care | 5 | 2023 | 93 | 0.950 |
Why?
|
| Action Potentials | 6 | 2020 | 246 | 0.950 |
Why?
|
| Obstetric Labor Complications | 2 | 2016 | 9 | 0.950 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2025 | 92 | 0.930 |
Why?
|
| Pulmonary Embolism | 3 | 2021 | 38 | 0.930 |
Why?
|
| Trial of Labor | 2 | 2015 | 4 | 0.930 |
Why?
|
| Electrophysiological Phenomena | 1 | 2025 | 20 | 0.930 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2025 | 3 | 0.910 |
Why?
|
| Eclampsia | 2 | 2023 | 12 | 0.910 |
Why?
|
| Prefrontal Cortex | 2 | 2017 | 164 | 0.870 |
Why?
|
| Maternal Exposure | 1 | 2025 | 57 | 0.870 |
Why?
|
| Substance-Related Disorders | 2 | 2023 | 830 | 0.860 |
Why?
|
| Length of Stay | 5 | 2025 | 229 | 0.850 |
Why?
|
| Manganese | 3 | 2024 | 92 | 0.840 |
Why?
|
| Anti-Anxiety Agents | 1 | 2023 | 19 | 0.820 |
Why?
|
| Internet | 1 | 2025 | 236 | 0.820 |
Why?
|
| Placenta Accreta | 4 | 2025 | 5 | 0.810 |
Why?
|
| Influenza, Human | 2 | 2021 | 92 | 0.790 |
Why?
|
| Patient Discharge | 7 | 2020 | 128 | 0.770 |
Why?
|
| Pesticides | 2 | 2024 | 62 | 0.770 |
Why?
|
| Habenula | 3 | 2013 | 4 | 0.770 |
Why?
|
| Alcohol Drinking | 2 | 2025 | 609 | 0.760 |
Why?
|
| Ethanol | 1 | 2025 | 224 | 0.750 |
Why?
|
| Hypertension | 3 | 2024 | 835 | 0.750 |
Why?
|
| Intraoperative Complications | 2 | 2023 | 20 | 0.740 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 57 | 0.740 |
Why?
|
| Guideline Adherence | 2 | 2021 | 98 | 0.740 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 27 | 0.730 |
Why?
|
| Depressive Disorder | 3 | 2009 | 187 | 0.730 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 56 | 0.730 |
Why?
|
| Postthrombotic Syndrome | 1 | 2021 | 1 | 0.730 |
Why?
|
| Tooth, Deciduous | 1 | 2021 | 2 | 0.720 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 71 | 0.720 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 30 | 0.710 |
Why?
|
| Marijuana Abuse | 1 | 2023 | 100 | 0.690 |
Why?
|
| Risk Adjustment | 1 | 2021 | 18 | 0.690 |
Why?
|
| Stress, Physiological | 2 | 2025 | 172 | 0.680 |
Why?
|
| Animals | 22 | 2025 | 16992 | 0.680 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.670 |
Why?
|
| Health Services | 1 | 2021 | 61 | 0.660 |
Why?
|
| Epilepsy | 1 | 2021 | 59 | 0.660 |
Why?
|
| Huntington Disease | 1 | 2020 | 31 | 0.660 |
Why?
|
| Endocannabinoids | 1 | 2021 | 41 | 0.660 |
Why?
|
| Severity of Illness Index | 6 | 2021 | 719 | 0.640 |
Why?
|
| Puerperal Infection | 1 | 2020 | 1 | 0.640 |
Why?
|
| Prisoners | 1 | 2022 | 102 | 0.640 |
Why?
|
| Veterans | 1 | 2022 | 210 | 0.640 |
Why?
|
| Antidepressive Agents | 4 | 2023 | 65 | 0.640 |
Why?
|
| Middle Aged | 19 | 2025 | 12222 | 0.630 |
Why?
|
| Neurons | 7 | 2025 | 1263 | 0.630 |
Why?
|
| Sucrose | 3 | 2025 | 33 | 0.630 |
Why?
|
| Depression | 4 | 2023 | 863 | 0.620 |
Why?
|
| Gestational Age | 5 | 2025 | 200 | 0.610 |
Why?
|
| Dopamine | 3 | 2021 | 275 | 0.610 |
Why?
|
| Depression, Postpartum | 1 | 2019 | 16 | 0.600 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2025 | 1766 | 0.600 |
Why?
|
| Learning | 1 | 2020 | 161 | 0.600 |
Why?
|
| Medicaid | 4 | 2023 | 143 | 0.590 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 117 | 0.580 |
Why?
|
| Cohort Studies | 7 | 2025 | 1759 | 0.580 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 749 | 0.570 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 120 | 0.570 |
Why?
|
| Anesthesia, Obstetrical | 2 | 2018 | 8 | 0.570 |
Why?
|
| Child | 8 | 2024 | 3443 | 0.540 |
Why?
|
| Models, Theoretical | 2 | 2016 | 232 | 0.530 |
Why?
|
| Iron | 3 | 2024 | 251 | 0.530 |
Why?
|
| Asthma | 1 | 2021 | 416 | 0.520 |
Why?
|
| Twins | 1 | 2017 | 19 | 0.520 |
Why?
|
| Odds Ratio | 4 | 2019 | 587 | 0.520 |
Why?
|
| Neoplasms | 2 | 2025 | 1377 | 0.510 |
Why?
|
| Heart Rate | 2 | 2025 | 266 | 0.500 |
Why?
|
| Placenta | 3 | 2022 | 117 | 0.500 |
Why?
|
| Cocaine-Related Disorders | 3 | 2013 | 102 | 0.490 |
Why?
|
| Male | 18 | 2025 | 23409 | 0.490 |
Why?
|
| Self Administration | 6 | 2024 | 69 | 0.490 |
Why?
|
| Linear Models | 4 | 2021 | 317 | 0.480 |
Why?
|
| Rats, Long-Evans | 3 | 2025 | 108 | 0.480 |
Why?
|
| Deep Brain Stimulation | 3 | 2013 | 17 | 0.470 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 590 | 0.460 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2015 | 6 | 0.460 |
Why?
|
| Obesity | 5 | 2023 | 1151 | 0.460 |
Why?
|
| Motor Activity | 4 | 2010 | 437 | 0.460 |
Why?
|
| Medicare | 5 | 2021 | 332 | 0.450 |
Why?
|
| Obstetrics | 4 | 2021 | 43 | 0.450 |
Why?
|
| Health Status Disparities | 2 | 2021 | 719 | 0.450 |
Why?
|
| Aging | 1 | 2020 | 783 | 0.450 |
Why?
|
| Stockings, Compression | 1 | 2014 | 1 | 0.440 |
Why?
|
| Intermittent Pneumatic Compression Devices | 1 | 2014 | 2 | 0.440 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2014 | 9 | 0.440 |
Why?
|
| Software | 3 | 2024 | 236 | 0.440 |
Why?
|
| Choice Behavior | 1 | 2015 | 93 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 760 | 0.430 |
Why?
|
| Cluster Analysis | 1 | 2015 | 207 | 0.430 |
Why?
|
| Preconception Care | 1 | 2014 | 12 | 0.430 |
Why?
|
| Desipramine | 3 | 2009 | 13 | 0.410 |
Why?
|
| Endocrine Disruptors | 2 | 2024 | 44 | 0.410 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 235 | 0.400 |
Why?
|
| Echocardiography | 1 | 2014 | 167 | 0.400 |
Why?
|
| Brain | 5 | 2025 | 1472 | 0.370 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1596 | 0.360 |
Why?
|
| Lead | 2 | 2023 | 100 | 0.350 |
Why?
|
| Critical Care | 2 | 2021 | 49 | 0.340 |
Why?
|
| Body Temperature | 1 | 2010 | 35 | 0.330 |
Why?
|
| Risk Assessment | 3 | 2019 | 863 | 0.320 |
Why?
|
| Logistic Models | 5 | 2025 | 1009 | 0.320 |
Why?
|
| Demography | 2 | 2023 | 195 | 0.320 |
Why?
|
| Parity | 2 | 2021 | 59 | 0.310 |
Why?
|
| Risk | 3 | 2021 | 287 | 0.310 |
Why?
|
| Verbal Learning | 3 | 2023 | 18 | 0.310 |
Why?
|
| Cocaine | 3 | 2013 | 251 | 0.300 |
Why?
|
| Interneurons | 2 | 2020 | 65 | 0.290 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2021 | 104 | 0.290 |
Why?
|
| Prevalence | 4 | 2019 | 1612 | 0.290 |
Why?
|
| Confidence Intervals | 2 | 2019 | 162 | 0.280 |
Why?
|
| Stress, Psychological | 2 | 2025 | 661 | 0.280 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 236 | 0.280 |
Why?
|
| Child, Preschool | 2 | 2023 | 1546 | 0.280 |
Why?
|
| Prospective Studies | 3 | 2024 | 1600 | 0.270 |
Why?
|
| Analysis of Variance | 3 | 2019 | 575 | 0.270 |
Why?
|
| Hospital Costs | 2 | 2025 | 27 | 0.270 |
Why?
|
| Status Asthmaticus | 2 | 2016 | 2 | 0.250 |
Why?
|
| Coma | 2 | 2016 | 7 | 0.250 |
Why?
|
| Delirium | 2 | 2016 | 11 | 0.250 |
Why?
|
| Liver Failure, Acute | 2 | 2016 | 5 | 0.250 |
Why?
|
| Status Epilepticus | 2 | 2016 | 15 | 0.250 |
Why?
|
| Limbic System | 1 | 2007 | 31 | 0.250 |
Why?
|
| Cerebrovascular Disorders | 2 | 2016 | 43 | 0.240 |
Why?
|
| Algorithms | 3 | 2016 | 509 | 0.240 |
Why?
|
| Postnatal Care | 2 | 2022 | 16 | 0.240 |
Why?
|
| Prostheses and Implants | 1 | 2025 | 18 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 223 | 0.230 |
Why?
|
| Ovarian Neoplasms | 2 | 2020 | 415 | 0.230 |
Why?
|
| Neural Pathways | 3 | 2020 | 138 | 0.230 |
Why?
|
| Sepsis | 2 | 2016 | 90 | 0.230 |
Why?
|
| Insulin Infusion Systems | 1 | 2025 | 8 | 0.230 |
Why?
|
| Hemorrhage | 2 | 2023 | 55 | 0.230 |
Why?
|
| Pregnancy Trimesters | 1 | 2025 | 15 | 0.230 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2025 | 33 | 0.230 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2024 | 15 | 0.220 |
Why?
|
| Ghrelin | 1 | 2025 | 17 | 0.220 |
Why?
|
| Oxycodone | 1 | 2024 | 7 | 0.220 |
Why?
|
| Incidence | 3 | 2024 | 1078 | 0.210 |
Why?
|
| Insurance Coverage | 1 | 2025 | 110 | 0.210 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2024 | 46 | 0.210 |
Why?
|
| Cosmetics | 1 | 2024 | 10 | 0.210 |
Why?
|
| Regression Analysis | 2 | 2016 | 490 | 0.210 |
Why?
|
| Gastrointestinal Tract | 1 | 2025 | 71 | 0.210 |
Why?
|
| Fluoxetine | 1 | 2023 | 15 | 0.210 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 247 | 0.200 |
Why?
|
| Bayes Theorem | 4 | 2024 | 126 | 0.200 |
Why?
|
| Prognosis | 2 | 2018 | 861 | 0.200 |
Why?
|
| Meningomyelocele | 1 | 2023 | 1 | 0.200 |
Why?
|
| Fontan Procedure | 1 | 2023 | 11 | 0.200 |
Why?
|
| Hypoglycemic Agents | 1 | 2025 | 184 | 0.200 |
Why?
|
| Computer Simulation | 1 | 2025 | 408 | 0.190 |
Why?
|
| Gulf War | 1 | 2022 | 1 | 0.190 |
Why?
|
| Quality of Health Care | 2 | 2021 | 161 | 0.190 |
Why?
|
| Seizures | 1 | 2023 | 79 | 0.190 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 94 | 0.190 |
Why?
|
| Mice | 4 | 2024 | 6644 | 0.180 |
Why?
|
| Intrauterine Devices | 1 | 2022 | 19 | 0.180 |
Why?
|
| Dentin | 1 | 2021 | 3 | 0.180 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 287 | 0.180 |
Why?
|
| Societies, Medical | 2 | 2021 | 74 | 0.180 |
Why?
|
| Copper | 1 | 2023 | 134 | 0.180 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 665 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2021 | 40 | 0.170 |
Why?
|
| Specialization | 1 | 2021 | 26 | 0.170 |
Why?
|
| Poisson Distribution | 1 | 2021 | 44 | 0.170 |
Why?
|
| Hematocrit | 2 | 2020 | 26 | 0.170 |
Why?
|
| Blood Transfusion | 4 | 2025 | 31 | 0.170 |
Why?
|
| Models, Animal | 3 | 2010 | 151 | 0.170 |
Why?
|
| Photometry | 1 | 2020 | 5 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2021 | 72 | 0.170 |
Why?
|
| Parvalbumins | 1 | 2020 | 17 | 0.170 |
Why?
|
| Task Performance and Analysis | 1 | 2020 | 47 | 0.170 |
Why?
|
| Discrimination Learning | 1 | 2020 | 38 | 0.160 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2020 | 17 | 0.160 |
Why?
|
| Dyspnea | 1 | 2020 | 22 | 0.160 |
Why?
|
| Time Factors | 3 | 2018 | 1857 | 0.160 |
Why?
|
| Crohn Disease | 1 | 2021 | 71 | 0.160 |
Why?
|
| Cough | 1 | 2020 | 20 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 298 | 0.160 |
Why?
|
| Feeding Behavior | 1 | 2024 | 469 | 0.160 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 310 | 0.160 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2020 | 40 | 0.160 |
Why?
|
| Comorbidity | 2 | 2020 | 737 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 252 | 0.160 |
Why?
|
| Fever | 1 | 2020 | 62 | 0.160 |
Why?
|
| Endometrial Neoplasms | 1 | 2021 | 79 | 0.160 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 74 | 0.160 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 22 | 0.160 |
Why?
|
| Dystocia | 1 | 2019 | 6 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 36 | 0.160 |
Why?
|
| alpha-Synuclein | 1 | 2020 | 61 | 0.150 |
Why?
|
| Nucleus Accumbens | 2 | 2013 | 100 | 0.150 |
Why?
|
| Nerve Net | 1 | 2020 | 101 | 0.150 |
Why?
|
| Cognition | 1 | 2023 | 473 | 0.150 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2019 | 14 | 0.150 |
Why?
|
| Axons | 1 | 2020 | 117 | 0.150 |
Why?
|
| Health Care Costs | 1 | 2020 | 91 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2019 | 36 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2021 | 263 | 0.150 |
Why?
|
| New York | 1 | 2019 | 93 | 0.150 |
Why?
|
| Ferritins | 3 | 2024 | 63 | 0.150 |
Why?
|
| Gynecology | 1 | 2019 | 35 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 126 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2021 | 760 | 0.150 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 67 | 0.150 |
Why?
|
| Hospital Charges | 1 | 2018 | 15 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 278 | 0.140 |
Why?
|
| Labor Onset | 1 | 2018 | 1 | 0.140 |
Why?
|
| Multiple Birth Offspring | 1 | 2018 | 2 | 0.140 |
Why?
|
| Labor Presentation | 1 | 2018 | 3 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 23 | 0.140 |
Why?
|
| Aged | 5 | 2021 | 8214 | 0.140 |
Why?
|
| Basal Ganglia | 1 | 2017 | 21 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2020 | 210 | 0.140 |
Why?
|
| Electric Stimulation | 2 | 2010 | 186 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2021 | 1604 | 0.130 |
Why?
|
| Air Pollution | 1 | 2018 | 87 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 192 | 0.130 |
Why?
|
| Intelligence Tests | 1 | 2017 | 8 | 0.130 |
Why?
|
| Fetal Death | 1 | 2017 | 18 | 0.130 |
Why?
|
| Mental Health | 1 | 2021 | 385 | 0.130 |
Why?
|
| California | 1 | 2019 | 548 | 0.130 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2008 | 15 | 0.130 |
Why?
|
| Uterine Hemorrhage | 1 | 2016 | 14 | 0.130 |
Why?
|
| Synaptic Transmission | 2 | 2008 | 149 | 0.120 |
Why?
|
| Telemedicine | 1 | 2020 | 234 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 15 | 0.120 |
Why?
|
| Markov Chains | 1 | 2016 | 43 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 49 | 0.120 |
Why?
|
| Acute Disease | 1 | 2016 | 155 | 0.120 |
Why?
|
| ROC Curve | 1 | 2016 | 159 | 0.120 |
Why?
|
| Swimming | 2 | 2007 | 41 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 165 | 0.120 |
Why?
|
| Cesarean Section, Repeat | 1 | 2015 | 2 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2025 | 2157 | 0.110 |
Why?
|
| Caudate Nucleus | 1 | 2015 | 22 | 0.110 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 31 | 0.110 |
Why?
|
| Uterine Rupture | 1 | 2015 | 5 | 0.110 |
Why?
|
| Automation | 1 | 2015 | 22 | 0.110 |
Why?
|
| Electrodes | 1 | 2015 | 59 | 0.110 |
Why?
|
| Health Promotion | 1 | 2021 | 704 | 0.110 |
Why?
|
| Maze Learning | 1 | 2015 | 113 | 0.110 |
Why?
|
| Thrombophilia | 1 | 2014 | 5 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 638 | 0.110 |
Why?
|
| New York City | 3 | 2020 | 288 | 0.110 |
Why?
|
| Counseling | 1 | 2015 | 138 | 0.110 |
Why?
|
| Environment | 1 | 2015 | 149 | 0.100 |
Why?
|
| Perinatal Mortality | 1 | 2013 | 4 | 0.100 |
Why?
|
| Conditioning, Operant | 2 | 2013 | 90 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 539 | 0.100 |
Why?
|
| Receptors, Opioid, delta | 1 | 2013 | 23 | 0.100 |
Why?
|
| beta-Endorphin | 1 | 2013 | 17 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2014 | 112 | 0.100 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 111 | 0.100 |
Why?
|
| Metals | 2 | 2024 | 114 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1869 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1081 | 0.090 |
Why?
|
| Magnesium Sulfate | 1 | 2010 | 5 | 0.080 |
Why?
|
| Tocolytic Agents | 1 | 2010 | 4 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2025 | 549 | 0.080 |
Why?
|
| Fetus | 1 | 2010 | 101 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 284 | 0.080 |
Why?
|
| Paroxetine | 1 | 2009 | 3 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 2853 | 0.080 |
Why?
|
| Amphetamine | 1 | 2009 | 21 | 0.070 |
Why?
|
| Dopamine Agents | 1 | 2009 | 28 | 0.070 |
Why?
|
| Rats, Transgenic | 1 | 2008 | 34 | 0.070 |
Why?
|
| Intelligence | 2 | 2019 | 15 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 78 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2010 | 129 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 81 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 883 | 0.070 |
Why?
|
| Fourier Analysis | 1 | 2008 | 45 | 0.070 |
Why?
|
| Smoking | 1 | 2014 | 1024 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2008 | 66 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1271 | 0.070 |
Why?
|
| Social Behavior | 1 | 2008 | 161 | 0.060 |
Why?
|
| Rats, Mutant Strains | 1 | 2007 | 7 | 0.060 |
Why?
|
| Rats, Inbred Strains | 1 | 2005 | 126 | 0.060 |
Why?
|
| Hunger | 1 | 2025 | 12 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 153 | 0.060 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2024 | 21 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2024 | 55 | 0.050 |
Why?
|
| Diuretics | 1 | 2024 | 51 | 0.050 |
Why?
|
| Inflammation | 1 | 2010 | 758 | 0.050 |
Why?
|
| Specialties, Surgical | 1 | 2024 | 7 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2024 | 42 | 0.050 |
Why?
|
| Parabens | 1 | 2024 | 9 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2024 | 60 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2025 | 145 | 0.050 |
Why?
|
| Chromium | 1 | 2023 | 28 | 0.050 |
Why?
|
| Motivation | 1 | 2008 | 513 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2024 | 122 | 0.050 |
Why?
|
| Reproduction | 1 | 2024 | 94 | 0.050 |
Why?
|
| Insulin | 1 | 2025 | 258 | 0.050 |
Why?
|
| Italy | 1 | 2023 | 27 | 0.050 |
Why?
|
| Phenols | 1 | 2024 | 107 | 0.050 |
Why?
|
| Medical Records | 1 | 2022 | 48 | 0.050 |
Why?
|
| Contraception Behavior | 1 | 2022 | 33 | 0.050 |
Why?
|
| Cell Count | 2 | 2013 | 145 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 48 | 0.040 |
Why?
|
| Massachusetts | 1 | 2021 | 35 | 0.040 |
Why?
|
| Contraception | 1 | 2022 | 60 | 0.040 |
Why?
|
| Morbidity | 1 | 2021 | 97 | 0.040 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 10 | 0.040 |
Why?
|
| Poverty | 1 | 2023 | 400 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2019 | 42 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 160 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 206 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2019 | 33 | 0.040 |
Why?
|
| Fetal Development | 1 | 2019 | 34 | 0.040 |
Why?
|
| Maternal Health Services | 1 | 2019 | 23 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2019 | 32 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2020 | 108 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 61 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 55 | 0.040 |
Why?
|
| Nitrogen Dioxide | 1 | 2018 | 17 | 0.040 |
Why?
|
| Child Development | 1 | 2019 | 99 | 0.040 |
Why?
|
| Income | 1 | 2019 | 160 | 0.040 |
Why?
|
| Birth Certificates | 1 | 2018 | 5 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 611 | 0.040 |
Why?
|
| Particulate Matter | 1 | 2018 | 83 | 0.030 |
Why?
|
| Research | 1 | 2019 | 181 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 385 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1285 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 1175 | 0.030 |
Why?
|
| Family | 1 | 2017 | 195 | 0.030 |
Why?
|
| Efferent Pathways | 1 | 2013 | 16 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2013 | 37 | 0.030 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2013 | 83 | 0.020 |
Why?
|
| Cues | 1 | 2013 | 81 | 0.020 |
Why?
|
| Extinction, Psychological | 1 | 2013 | 104 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2010 | 16 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1124 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 60 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 75 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 147 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 148 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 95 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2010 | 132 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 455 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2010 | 239 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 386 | 0.020 |
Why?
|
| Cytokines | 1 | 2010 | 678 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1621 | 0.010 |
Why?
|